Ola Wlodek
Ola is the CEO of Constructive Bio, a spinout from Jason Chin’s lab in Cambridge, UK. The company is dedicated to broadening the range of building blocks for peptides and proteins produced recombinantly, leveraging cutting-edge synthetic genomics and engineered translation to unlock new possibilities for biopharma and beyond. Ola holds a PhD in Biological Sciences from the University of Cambridge and an Executive MBA from Warwick Business School, combining deep scientific expertise with strategic leadership skills. Her scientific career has been driven by a fascination with designing and producing ‘unnatural’ products through biological means—transforming synthetic biology from exploration to purposeful innovation.
Constructive Bio
Strategic Alliances: How Pharma Thinks About Computational Drug Discovery Partnerships
-
This session explores how pharma companies approach and build effective partnerships with computational drug discovery firms. Industry experts will share insights on best practices for data sharing, strategies for navigating cultural challenges with AI-driven startups, and the role of explainable AI in fostering trust. The discussion will also cover common mistakes AI biotech companies make when approaching pharma and the considerations around using proprietary algorithms versus open-source models to advance drug discovery.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
